Bruck Kifle

Array ( [id] => 5591676 [patent_doc_number] => 20060041128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Selected fused heterocyclics and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/206888 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37847 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20060041128.pdf [firstpage_image] =>[orig_patent_app_number] => 11206888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829026 [patent_doc_number] => 20060063751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Novel fused heterocycles and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/207089 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88135 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063751.pdf [firstpage_image] =>[orig_patent_app_number] => 11207089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591677 [patent_doc_number] => 20060041129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Enantiomers of selected fused heterocyclics and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/207128 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37259 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20060041129.pdf [firstpage_image] =>[orig_patent_app_number] => 11207128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411703 [patent_doc_number] => 07282505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Rapamycin polymorphs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/206472 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7649 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282505.pdf [firstpage_image] =>[orig_patent_app_number] => 11206472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691437 [patent_doc_number] => 20070232596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Benzothienopyridines for Use as Inhibitors of Eg5 Kinesin' [patent_app_type] => utility [patent_app_number] => 11/659738 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14847 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232596.pdf [firstpage_image] =>[orig_patent_app_number] => 11659738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211052 [patent_doc_number] => 20070249636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Selected Fused Heterocyclics and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/573671 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23988 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249636.pdf [firstpage_image] =>[orig_patent_app_number] => 11573671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960614 [patent_doc_number] => 20080275039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Geldanamycin Derivatives and the Method for Biosynthesis Thereof' [patent_app_type] => utility [patent_app_number] => 11/573503 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275039.pdf [firstpage_image] =>[orig_patent_app_number] => 11573503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570354 [patent_doc_number] => 20090253732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Production Of Polyketides And Other Natural Products' [patent_app_type] => utility [patent_app_number] => 11/659936 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36210 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253732.pdf [firstpage_image] =>[orig_patent_app_number] => 11659936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629401 [patent_doc_number] => 08008288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Anti-inflammatory A-aminocyclolactam compounds' [patent_app_type] => utility [patent_app_number] => 11/573851 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5692 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008288.pdf [firstpage_image] =>[orig_patent_app_number] => 11573851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629402 [patent_doc_number] => 08008289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'α-aminocyclolactam ligands for G-protein coupled receptors' [patent_app_type] => utility [patent_app_number] => 11/574656 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7484 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008289.pdf [firstpage_image] =>[orig_patent_app_number] => 11574656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907728 [patent_doc_number] => 07332601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'CCI-779 derivatives and methods of making same' [patent_app_type] => utility [patent_app_number] => 11/200383 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2924 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332601.pdf [firstpage_image] =>[orig_patent_app_number] => 11200383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265570 [patent_doc_number] => 20090118255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Crp Lowering Agent' [patent_app_type] => utility [patent_app_number] => 11/659941 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118255.pdf [firstpage_image] =>[orig_patent_app_number] => 11659941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771646 [patent_doc_number] => 20050267097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Lactam-containing compounds and derivatives thereof as factor xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/198801 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80399 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267097.pdf [firstpage_image] =>[orig_patent_app_number] => 11198801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 468878 [patent_doc_number] => 07232799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-19 [patent_title] => 'Streptogramin derivatives and compositions thereof' [patent_app_type] => utility [patent_app_number] => 11/193164 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11538 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232799.pdf [firstpage_image] =>[orig_patent_app_number] => 11193164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931841 [patent_doc_number] => 20050282876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Inhibitors of IMPDH enzyme' [patent_app_type] => utility [patent_app_number] => 11/192657 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15146 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282876.pdf [firstpage_image] =>[orig_patent_app_number] => 11192657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472800 [patent_doc_number] => 07229996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Rifamycin derivatives' [patent_app_type] => utility [patent_app_number] => 11/186187 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229996.pdf [firstpage_image] =>[orig_patent_app_number] => 11186187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 475453 [patent_doc_number] => 07226931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => '(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/186425 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9544 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226931.pdf [firstpage_image] =>[orig_patent_app_number] => 11186425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779467 [patent_doc_number] => 20080287465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/632920 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19848 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287465.pdf [firstpage_image] =>[orig_patent_app_number] => 11632920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769225 [patent_doc_number] => 20060019946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => '3-(4-Piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one' [patent_app_type] => utility [patent_app_number] => 11/185593 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2322 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019946.pdf [firstpage_image] =>[orig_patent_app_number] => 11185593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131601 [patent_doc_number] => 20070207998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Muscarinic Antagonists With Parp and Sir Modulating Activity as Agents for Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 11/632648 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11512 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207998.pdf [firstpage_image] =>[orig_patent_app_number] => 11632648 [rel_patent_id] =>[rel_patent_doc_number] =>)